AstraZeneca logo

Associate Director, Market Access Policy Analytics

AstraZeneca

Wilmington, DEOnsitePosted 1 day ago
Full TimeDirector & AboveCommercial & Pharma SalesPharmaceutical
Original posting ↗

Summary

US Market Access operates in a complex and dynamic policy environment that presents significant business risks and opportunities. The volume and pace of policy change – including federal rule making, state legislation, and 340B developments – have accelerated in the last several years, creating considerable complexity for understanding the myriad impacts to patients, customers, and our business.

Job description

The Market Access Policy Implementation & Analytics team is responsible for analyzing the impact of market access policy changes for the US BBU and implementing those policy changes into our US Market Access operations, increasing our ability to respond quickly and consistently to policy developments. The team also represents US Market Access and BBU internally to AZ teams working on external policy advocacy, and delivers actionable landscape analyses to inform advocacy priorities, forecasts, and business planning. The team has accountability for 340B program integrity, strengthening integrity and transparency by tightening contract pharmacy controls, advancing data-driven monitoring and payer scrubbing, and accomplishing policy solutions that reduce diversion, duplicate discounts, and compliance risk.

The Associate Director, Market Access Policy Analytics contributes across the team’s scope of responsibility, with a primary focus on policy analytics and access landscape analyses. This role is responsible for leading policy financial impact assessments in partnership with finance and other business units. This role is also accountable for delivering market access landscape analyses and conducting related primary and secondary research. The role partners closely with teams across US Market Access and beyond, including US Policy & Government Affairs, Finance, Global Market Access, Access Strategy, Account Directors, Legal, Compliance, and other business units. This role reports to the Senior Director, Market Access Policy Implementation & Analytics.

Main Duties and Responsibilities

  • Model the financial and gross-to-net impacts of federal and state health policy proposals on the US biopharmaceuticals business and US Market Access. Policy areas include MFN, IRA, 340B, PFS, Medicare Part D, Medicaid, PDABs, UPLs, and PBM reform
  • Develop executive-ready policy analytics outputs and communicate results to senior leaders, including associated financial, operational, and access implications and recommendations
  • Build and maintain analytical models, frameworks, and templates that can be reused across policy areas and refreshed as policy evolves
  • Deliver qualitative and quantitative analyses of the US market access ecosystem, comprising current state and future trends, that are suited for informing senior leader decision-making and brand strategy. Example focus areas include PBM reform, Part D market evolution, and covered entities’ approach to 340B
  • Conduct primary and secondary market research to inform landscape analyses
  • Select and manage research vendors, and partner closely with customer-facing teams to consolidate their insights into formal analyses
  • Contribute to policy implementation and external advocacy workstreams, including through analytics and research support

Essential Requirements

  • Bachelor’s degree
  • 5+ years of pharmaceutical or related healthcare business experience
  • Deep understanding of pharmaceutical market access and healthcare delivery
  • Experience analyzing and interpreting federal or state healthcare policies and assessing implications for pharmaceutical market access
  • Demonstrated financial modeling experience in a commercial, pricing, or policy context
  • Experience conducting primary and secondary market research and translating results into actionable recommendations
  • Demonstrated proficiency using AI tools to synthesize information, generate insights, and produce high-quality business deliverables
  • Strong written and verbal communication skills, including preparation of leadership presentations, briefing materials, and recommendations

Desirable Requirements, Skills and Capabilities

  • Advanced degree in a relevant field (MPH, MPP, JD, MBA, PharmD, PhD, or similar)
  • Extensive knowledge of US federal and state health policy, including MFN, IRA, 340B, Medicare, Medicaid, PBM reform, and PDABs
  • Experience in health policy consulting, market access consulting, policy analytics, finance, or customer-facing roles within the pharmaceutical or healthcare industry
  • Working knowledge of US pharmaceutical gross-to-net components, rebate and chargeback mechanisms, and government pricing mechanisms, including ASP, Best Price, URA, 340B, and statutory discounts

Requirements

  • Bachelor’s degree
  • 5+ years of pharmaceutical or related healthcare business experience
  • Deep understanding of pharmaceutical market access and healthcare delivery
  • Experience analyzing and interpreting federal or state healthcare policies and assessing implications for pharmaceutical market access
  • Demonstrated financial modeling experience in a commercial, pricing, or policy context
  • Experience conducting primary and secondary market research and translating results into actionable recommendations
  • Demonstrated proficiency using AI tools to synthesize information, generate insights, and produce high-quality business deliverables
  • Strong written and verbal communication skills, including preparation of leadership presentations, briefing materials, and recommendations

Benefits

  • Inclusive culture
  • Lifelong learning
  • Growth and development opportunities

Company overview

AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.